Skip to main content


Fig. 2 | Chinese Journal of Cancer

Fig. 2

From: Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study

Fig. 2

Nomogram-predicted probabilities of the 1-, 2-, and 3-year OS of patients with intermediate to advanced HCC who received TACE with or without H101. The nomogram is used by adding the points identified on the “Point” scale for six variables. The sum is located on the “Total points” scale, and a line is drawn downward to the survival axes to determine the probability of 1-, 2-, and 3-year OS. ALP alkaline phosphatase, AFP alpha-fetoprotein

Back to article page